5th Circuit’s Mifepristone Stay Triggers SCOTUS Emergency InterventionMay 29, 2026Legal NewsA unanimous 5th Circuit panel reinstated in-person mifepristone rules nationwide on May 1, overriding the Trump administration's position before SCOTUS stepped in four days later.
Supreme Court Stays Fifth Circuit Order, Preserves Mifepristone Telehealth AccessMay 29, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit order that had reinstated in-person mifepristone dispensing rules, preserving telehealth access while litigation continues below.
Fifth Circuit Reinstates Mifepristone In-Person Dispensing Requirement NationwideMay 22, 2026Legal NewsThe Fifth Circuit reinstated mifepristone's in-person dispensing requirement nationwide on May 1, accepting Louisiana's Medicaid-cost standing theory before the Supreme Court intervened May 4.
Supreme Court Stays 5th Circuit Order Reinstating Mifepristone Dispensing RequirementMay 21, 2026Legal NewsThe Supreme Court blocked a 5th Circuit order that would have reinstated in-person mifepristone dispensing rules, with Thomas invoking the Comstock Act in dissent.
5th Circuit Orders Nationwide In-Person Mifepristone Dispensing, Prompting Emergency SCOTUS ActionMay 18, 2026Legal NewsA 5th Circuit panel reversed a district court stay and ordered nationwide in-person-only mifepristone dispensing, triggering emergency Supreme Court intervention in May 2026.
Supreme Court Stays Fifth Circuit Order on Mifepristone Dispensing RulesMay 16, 2026Legal NewsThe Supreme Court stayed a Fifth Circuit order reinstating in-person mifepristone rules, preserving telehealth access while signaling Comstock Act tensions ahead.
Fifth Circuit Blocks Mifepristone Mail Access, Drugmakers Rush to Supreme CourtMay 14, 2026Legal NewsThe Fifth Circuit ordered the FDA to reinstate in-person dispensing rules for mifepristone, blocking mail and telehealth access nationally. Drugmakers filed emergency Supreme Court applications.
5th Circuit Orders FDA to Reinstate Mifepristone In-Person RequirementMay 6, 2026Law and PolicyThe Fifth Circuit ordered the FDA to reinstate in-person mifepristone dispensing on May 1, 2026; the Supreme Court stayed the ruling three days later.